Annick Moureau

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul et al. · The Lancet · 2012 · 805 citations

Vaccination, Vaccine Safety, Vaccinology +8

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

Saranya Sridhar, Alexander R. Luedtke, Edith Langevin et al. · New England Journal of Medicine · 2018 · 756 citations · Full text

Symptomatic Dengue in Children in 10 Asian and Latin American Countries

Maïna L’Azou, Annick Moureau, Elsa Sarti et al. · New England Journal of Medicine · 2016 · 145 citations

Dengue serotype-specific seroprevalence among 5- to 10-year-old children in India: a community-based cross-sectional study

Suneela Garg, Anita Chakravarti, Ritesh Singh et al. · International Journal of Infectious Diseases · 2016 · 53 citations · Full text

Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial

Joshua Nealon, Anne-Frieda Taurel, Maria Rosario Capeding et al. · PLoS neglected tropical diseases · 2016 · 48 citations · Full text

Dengue Incidence, Disease Outbreak, Symptomatic Dengue Disease +18